Key Statistics
Market Cap$385.50M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$1.87
52W High$6.96
52W Low$1.35
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees45
Price Performance
1 Week+4.95%
3 Month+10.42%
1 Year-32.70%
FinancialsAnnual · QuiverQuant
Revenue$0
Assets$147.26M
Liabilities$96.16M
Net Income$101.17M loss
About
X4 Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the research, development, and commercialization of new therapies for the treatment of back diseases. The company is headquartered in Boston, Massachusetts.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze XFOR with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.